The content on this site is intended for healthcare professionals only
Dr Vaidya talks to ecancertv at the 3rd ESTRO about his presentation of new analysis on the TARGIT-A trial.
The findings showed that targeted intraoperative radiotherapy plus lumpectomy is non-inferior to external-beam radiotherapy (EBRT) in preventing breast cancer recurrence.
Quality of life and patient satisfaction of Filipinos after breast conservation surgery and intraoperative radiotherapy
Advancing breast cancer treatment in Uganda by improving molecular testing
Somatic mutation profile of breast cancer in Uganda
Breast and emerging indications for IORT
The advantages of IORT for early breast cancer treatment
The pros and cons of breast IORT and ultra hypofractionation (FR)
Global adoption of single-shot targeted IORT for breast cancer
The TARGIT-A randomised trial: TARGIT-IORT versus whole breast radiation therapy: long-term local control and survival
Insights from TARGIT-A trial of targeted IORT during lumpectomy for breast cancer
